Want to Subscribe?

MarketEye Archive

October 15, 2020
 

Is inflation a friend or foe?

October 2, 2020
 

Are we heading for a U-bend recovery?

September 15, 2020
 

A new look for resale

September 1, 2020
 

Is it crunch time for coal?

August 18, 2020
 

Why telemedicine matters in today’s markets

August 3, 2020
 

Can we build a better economic future?

July 21, 2020
 

A brief history of recessions and recoveries

July 7, 2020
 

What Covid-19 could mean for muni bond markets

June 9, 2020
 

Action stations

May 27, 2020
 

Beyond the clouds

May 12, 2020
 

Home advantage

April 28, 2020
 

Lessons from the past

April 14, 2020
 

The finite life of stranded assets

March 31, 2020
 

Fear at play

March 17, 2020
 

Feeling the squeeze

March 3, 2020
 

Turning of the tide

February 18, 2020
 

Store it away for a rainy day

February 4, 2020
 

The million-dollar question

January 22, 2020
 

A decade of promise

January 7, 2020
 

Music to your ears

December 23, 2019
 

Cool runnings

December 10, 2019
 

Science fiction prediction

November 26, 2019
 

30 is the new... homeowner?

November 12, 2019
 

The global GDP composition

October 31, 2019
 

The fear factor

October 15, 2019
 

Stormy weather

October 1, 2019
 

Biopharma's approach

Views expressed are those of the authors stated and do not reflect views of other managers or the firm overall. Views are current as of the date of this publication and subject to change. This material has been distributed for informational purposes only and should not be considered advice for investments or a recommendation of any particular investment, strategy, investment manager or account arrangement. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed. Please consult a legal, tax or investment advisor in order to determine whether an investment product or service is appropriate for a particular situation. No part of this material may be produced in any form, or referred to in any other publication, without express written permission. BNY Mellon Investment Adviser, Inc. and BNY Mellon Securities Corporation are subsidiaries of The Bank of New York Mellon Corporation.

MARK-38966-2018-10-15